ACHILLION PHARMACEUTICALS INC (CIK: 0001070336) EDGAR, Information, Filings... CompaniesBIO.Com

ACHILLION PHARMACEUTICALS INC

Mailing address
300 GEORGE STREET, NEW HAVEN, Delaware, 06511
Phone
203-624-7000
State location
Connecticut
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

ACHILLION PHARMACEUTICALS INC (CIK: 0001070336) is an American company incorporated in the state of Connecticut. Head office is located at 300 GEORGE STREET, NEW HAVEN, Connecticut, 06511. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. ACHILLION PHARMACEUTICALS INC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
G1 EXECUTION SERVICES, LLC	0001136305	Jan-27-2020	10 percent owner
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	0001446179	Jan-27-2020	10 percent owner
SUSQUEHANNA SECURITIES, LLC	0001446580	Jan-27-2020	10 percent owner
Di Donato Brian	0001766498	Feb-11-2019	officer: Chief Financial Officer
Lantz Keri	0001762858	Jan-01-2019	officer: See Remarks
Firuta Paul E	0001602727	Sep-10-2018	officer: Chief Operating Officer
Zelenkofske Steven	0001578333	Aug-20-2018	officer: Chief Medical Officer
Gibney Anthony S	0001750132	Aug-15-2018	officer: Chief Business Officer
MANNING MARTHA E	0001227894	Feb-01-2016	officer: EVP, General Counsel
Barrish Joel C	0001662803	Jan-04-2016	officer: Chief Scientific Officer
Verwiel Frank	0001545794	Dec-14-2015	director
JOHNSON & JOHNSON	0000200406	Jul-01-2015	10 percent owner
Johnson & Johnson Innovation - JJDC, Inc.	0000924020	Jul-01-2015	10 percent owner
RA Capital Healthcare Fund LP	0001315082	Sep-30-2013	10 percent owner
RA CAPITAL MANAGEMENT, LLC	0001346824	Sep-30-2013	10 percent owner
Kolchinsky Peter	0001384859	Sep-30-2013	10 percent owner
QVT Fund V LP	0001543904	Jul-02-2013	10 percent owner
Apelian David	0001546842	May-28-2013	officer: EVP and Chief Medical Officer
QVT Associates GP LLC	0001290166	Feb-22-2013	10 percent owner
Graves Kurt	0001406337	Jun-11-2012	director
FISHERMAN JASON S	0001197540	Dec-12-2011	director
Quaker BioVentures II LP	0001497725	Feb-15-2011	10 percent owner
Kamdar Kim P.	0001535065	Jan-01-2011	10 percent owner
DOMAIN ASSOCIATES	0001020733	Oct-06-2010	10 percent owner
TREU JESSE I	0001013425	Aug-20-2010	10 percent owner
BLAIR JAMES C	0001024000	Aug-20-2010	10 percent owner
VITULLO NICOLE	0001196863	Aug-20-2010	10 percent owner
DOVEY BRIAN H	0001207786	Aug-20-2010	10 percent owner
SCHOEMAKER KATHLEEN K	0001207789	Aug-20-2010	10 percent owner
Halak Brian K	0001354718	Aug-20-2010	10 percent owner
DP VIII Associates, L.P.	0001465143	Aug-20-2010	10 percent owner
Domain Partners VIII, L.P.	0001465144	Aug-20-2010	10 percent owner
Truitt Joseph	0001452429	Jan-05-2009	officer: VP, Chief Commercial Officer
Liotta Dennis	0001448270	Dec-15-2008	director
INVESTOR GROWTH CAPITAL LTD	0001237710	Dec-04-2008	10 percent owner
STEINMETZ MICHAEL	0001166285	Sep-05-2008	10 percent owner
HENNER DENNIS	0001249153	Sep-05-2008	10 percent owner
GALAKATOS NICHOLAS	0001252522	Sep-05-2008	10 percent owner
LIPTAK ROBERT	0001252523	Sep-05-2008	10 percent owner
WHEELER KURT	0001252525	Sep-05-2008	10 percent owner
Simon Nicholas	0001431403	Sep-05-2008	director, 10 percent owner
Leiden Jeffrey	0001431408	Sep-05-2008	10 percent owner
Clarus Ventures II, LLC	0001431437	Sep-05-2008	10 percent owner
Clarus Ventures II GP, L.P.	0001431439	Sep-05-2008	10 percent owner
Clarus Lifesciences II, L.P.	0001431443	Sep-05-2008	10 percent owner
INVESTOR AB	0000889232	Aug-12-2008	10 percent owner
Moorin Jay	0001033508	Aug-12-2008	10 percent owner
SCHREIBER ALAIN	0001225149	Aug-12-2008	10 percent owner
ProQuest Investments IV, L.P.	0001431818	Aug-12-2008	10 percent owner
ProQuest Associates IV LLC	0001431819	Aug-12-2008	10 percent owner
FRASHIER GARY E	0001215914	Mar-31-2008	director
Olek Elizabeth A	0001419066	Dec-06-2007	officer: Vice President and CMO
WRIGHT DAVID P	0001206342	Aug-20-2007	director
VAN NOSTRAND ROBERT L	0001225198	Apr-27-2007	director
GILEAD SCIENCES INC	0000882095	Oct-25-2006	10 percent owner
SCHRODER VENTURES MANAGERS INC	0001002632	Oct-25-2006	10 percent owner
FORMELA JEAN FRANCOIS	0001030575	Oct-25-2006	director, 10 percent owner
ADVENT INTERNATIONAL CORP/MA	0001034196	Oct-25-2006	other: Member of group > 10%
SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1	0001076081	Oct-25-2006	10 percent owner
KISHBAUCH MICHAEL D	0001076979	Oct-25-2006	director, officer: CEO and President
ATLAS VENTURE FUND V LP	0001106910	Oct-25-2006	10 percent owner
ATLAS VENTURE PARALLEL FUND V-A C V	0001133758	Oct-25-2006	10 percent owner
ATLAS VENTURE ASSOCIATES V LP	0001133805	Oct-25-2006	10 percent owner
ATLAS VENTURE ENTREPRENEURS FUND V LP	0001133807	Oct-25-2006	10 percent owner
SCHRODER VENTURE MANAGERS LTD	0001161844	Oct-25-2006	10 percent owner
RYSER STEFAN	0001166284	Oct-25-2006	director
ADVENT PARTNERS HLS II LIMITED PARTNERSHIP	0001197521	Oct-25-2006	other: Member of group > 10%
ADVENT PARTNERS LIMITED PARTNERSHIP	0001197526	Oct-25-2006	other: Member of group > 10%
ADVENT INTERNATIONAL LIMITED PARTNERSHIP	0001197534	Oct-25-2006	other: Member of group > 10%
ADVENT HEALTHCARE & LIFE SCIENCES II LP	0001197633	Oct-25-2006	other: Member of group > 10%
ADVENT HEALTHCARE & LIFE SCIENCES II KG	0001197635	Oct-25-2006	other: Member of group > 10%
GARVEY JAMES M	0001207314	Oct-25-2006	director, 10 percent owner
GREY MICHAEL G	0001240122	Oct-25-2006	director
WHITE CHRISTOPHER A	0001283401	Oct-25-2006	director
SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment Scheme	0001320569	Oct-25-2006	10 percent owner
Schroder Ventures International Life Sciences Fund II Strategic Partners L.P.	0001320570	Oct-25-2006	10 percent owner
Schroder Ventures International Life Sciences Fund II L.P.3	0001320571	Oct-25-2006	10 percent owner
Schroder Ventures International Life Sciences Fund II L.P.2	0001320572	Oct-25-2006	10 percent owner
SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTD	0001320585	Oct-25-2006	10 percent owner
Scheer David	0001378585	Oct-25-2006	director
Shah Gautam	0001378586	Oct-25-2006	officer: SVP and Chief Compliance Ofc.
Pottage John C Jr	0001378587	Oct-25-2006	officer: SVP and Chief Medical Officer
Deshpande Milind	0001378588	Oct-25-2006	officer: SVP and Chief Scientific Ofc.
Fenton Mary Kay	0001378589	Oct-25-2006	officer: Vice President and CFO

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ACHILLION PHARMACEUTICALS INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000354204-21-000634 (34 Act) Size: KB	Feb-16-2021	005-82163 21638147
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001140361-20-003382 (34 Act) Size: KB	Feb-14-2020	005-82163 20620753
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001493152-20-002369 (34 Act) Size: KB	Feb-14-2020	005-82163 20617416
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001258897-20-000748 (34 Act) Size: KB	Feb-12-2020	005-82163 20600955
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-20-017780 (34 Act) Size: KB	Feb-12-2020	005-82163 20599889
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000834237-20-008677 (34 Act) Size: KB	Feb-10-2020	005-82163 20589347
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001193125-20-027298 (34 Act) Size: KB	Feb-07-2020	001-33095 20584461
EFFECT	Document	Acc-no: 9999999995-20-000204 (33 Act) Size: KB	Jan-31-2020	333-216197 20566839
EFFECT	Document	Acc-no: 9999999995-20-000202 (33 Act) Size: KB	Jan-31-2020	333-161375 20566838
EFFECT	Document	Acc-no: 9999999995-20-000203 (33 Act) Size: KB	Jan-31-2020	333-169460 20566836
EFFECT	Document	Acc-no: 9999999995-20-000201 (33 Act) Size: KB	Jan-31-2020	333-153870 20566832
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-20-008815 ( Act) Size: 0 KB	Jan-30-2020
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001104659-20-008790 ( Act) Size: 0 KB	Jan-30-2020
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000904454-20-000088 ( Act) Size: 0 KB	Jan-29-2020
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-20-000679 ( Act) Size: 0 KB	Jan-29-2020
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-20-000678 ( Act) Size: 0 KB	Jan-29-2020
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-20-000677 ( Act) Size: 0 KB	Jan-29-2020
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-20-000676 ( Act) Size: 0 KB	Jan-29-2020
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-20-000675 ( Act) Size: 0 KB	Jan-29-2020
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001562180-20-000674 ( Act) Size: 0 KB	Jan-29-2020

Recent 20 filings. View all ACHILLION PHARMACEUTICALS INC filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

ACHILLION PHARMACEUTICALS INC overview
ACHILLION PHARMACEUTICALS INC job
ACHILLION PHARMACEUTICALS INC stock
ACHILLION PHARMACEUTICALS INC ownership
ACHILLION PHARMACEUTICALS INC CEO
ACHILLION PHARMACEUTICALS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.